Octapharma, an independent manufacturer of human protein products, has added the PAS-X Track & Trace Serialisation Aggregation solution to Werum's PAS-X at its production site in Vienna, Austria.
In a first step, PAS-X Track & Trace will be operated in the packaging area for the Chinese market. The serialisation data provided by the Chinese authorities is loaded and the used data is reported back. PAS-X Track & Trace is interfaced to the existing PAS-X and exchanges order and stock data with the MES.
Octapharma's core business is the development, production and sale of human proteins from human plasma and human cell-lines. Patients in over 100 countries are treated with products in the areas of haematology, immunotherapy and critical care. Octapharma owns five state-of-the-art production facilities in Austria, France, Germany, Sweden and Mexico.
It is intended to install Werum's PAS-X Track & Trace at further packaging lines for different target countries in the Vienna site.